UBS OCONNOR LLC - CLOVIS ONCOLOGY INC ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2021$998,000,000
-51.1%
1,000,000
-53.9%
0.01%
-69.0%
Q1 2021$2,040,000,000
+2.2%
2,170,0000.0%0.03%
-29.3%
Q4 2020$1,996,000,000
+1.1%
2,170,0000.0%0.04%
-18.0%
Q3 2020$1,975,000,000
+1.1%
2,170,0000.0%0.05%
+16.3%
Q2 2020$1,953,000,000
+118.2%
2,170,000
+117.0%
0.04%
+138.9%
Q1 2020$895,000,000
-88.8%
1,000,000
-91.4%
0.02%
-87.7%
Q1 2016$7,960,000,000
-6.8%
11,625,000
+16.2%
0.15%
+1.4%
Q4 2015$8,540,000,00010,000,0000.14%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 69,346,000$107,321,0003.81%
PFM Health Sciences, LP 34,710,000$53,670,0001.06%
Partner Investment Management, L.P. 556,000$860,0000.82%
Myriad Asset Management Ltd. 5,000,000$7,731,0000.75%
SYMPHONY ASSET MANAGEMENT LLC 4,000,000$6,185,0000.69%
CAPSTONE INVESTMENT ADVISORS, LLC 9,074,000$14,030,0000.49%
CSS LLC/IL 5,251,000$8,112,0000.40%
SSI INVESTMENT MANAGEMENT LLC 2,813,000$4,333,0000.37%
ADVENT CAPITAL MANAGEMENT /DE/ 7,131,000$11,056,0000.21%
D. E. Shaw & Co., Inc. 27,750,000$42,835,0000.07%
View complete list of CLOVIS ONCOLOGY INC shareholders